These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28823518)

  • 41. Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience.
    Bajko Z; Maier S; Motataianu A; Filep RC; Stoian A; Andone S; Balasa R
    Acta Neurol Belg; 2022 Feb; 122(1):105-111. PubMed ID: 33733345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes.
    Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D
    Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.
    Merli GJ; Hollander JE; Lefebvre P; Laliberté F; Raut MK; Germain G; Bookhart B; Pollack CV
    J Med Econ; 2016; 19(1):84-90. PubMed ID: 26390315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catheter-related upper limb venous thrombosis in a tertiary hospital setting.
    Ye X; Wong SW; Zhang J; Moo IH; Lee CC
    ANZ J Surg; 2016 Dec; 86(12):1033-1037. PubMed ID: 25287977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children.
    Menéndez JJ; Verdú C; Calderón B; Gómez-Zamora A; Schüffelmann C; de la Cruz JJ; de la Oliva P
    J Thromb Haemost; 2016 Nov; 14(11):2158-2168. PubMed ID: 27558946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents.
    Platton S; Bowles L; MacCallum P
    Br J Haematol; 2017 Nov; 179(3):511-513. PubMed ID: 27392166
    [No Abstract]   [Full Text] [Related]  

  • 51. Safety and efficacy of rivaroxaban compared with warfarin in patients undergoing peripheral arterial procedures.
    Talukdar A; Wang SK; Czosnowski L; Mokraoui N; Gupta A; Fajardo A; Dalsing M; Motaganahalli R
    J Vasc Surg; 2017 Oct; 66(4):1143-1148. PubMed ID: 28712814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent venous thrombosis under rivaroxaban and carbamazepine for symptomatic epilepsy.
    Stöllberger C; Finsterer J
    Neurol Neurochir Pol; 2017; 51(2):194-196. PubMed ID: 28215696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of venous thromboembolism in hospitalized patients with peripherally inserted central catheters.
    Lobo BL; Vaidean G; Broyles J; Reaves AB; Shorr RI
    J Hosp Med; 2009 Sep; 4(7):417-22. PubMed ID: 19753569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A RCT study of Rivaroxaban, low-molecular-weight heparin, and sequential medication regimens for the prevention of venous thrombosis after internal fixation of hip fracture.
    Tang Y; Wang K; Shi Z; Yang P; Dang X
    Biomed Pharmacother; 2017 Aug; 92():982-988. PubMed ID: 28605879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures.
    Xu X; Guo X; Wang R; Wang L; Li Q; Yi F; Li H; Qi X
    Ann Hepatol; 2020; 19(5):573-577. PubMed ID: 31521463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban.
    Yang H; Kim SR; Song MJ
    Clin Mol Hepatol; 2016 Dec; 22(4):499-502. PubMed ID: 27880998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.
    Hutten BA; Prins MH; Gent M; Ginsberg J; Tijssen JG; Büller HR
    J Clin Oncol; 2000 Sep; 18(17):3078-83. PubMed ID: 10963635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
    Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
    Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.